Upon ibrutinib treatment, a downmodulation of CXCR4 expression levels and CXCR4 signal inhibition in CLL cells could be identified in Eμ-TCL1 mice (185). The gene discussed is CXCR4; the disease is B-cell chronic lymphocytic leukemia.